How much funding has Minghui Pharmaceutical raised?

Minghui Pharmaceutical has raised $131.0M in total funding, most recently a venture unknown round.

Who are Minghui Pharmaceutical's investors?

Minghui Pharmaceutical's investors include OrbiMed, Qiming VP, TF Capital, BioTrack Capital, 5Y Capital, New Day Fund.

When was Minghui Pharmaceutical founded?

Minghui Pharmaceutical was founded in 2018.

Where is Minghui Pharmaceutical headquartered?

Minghui Pharmaceutical is headquartered in Shanghai, China.

What industry is Minghui Pharmaceutical in?

Minghui Pharmaceutical operates in Biotech, Healthcare.

How many employees does Minghui Pharmaceutical have?

Minghui Pharmaceutical has 11-50 employees.

Minghui Pharmaceutical

Shanghai, China · Founded 2018 · $131.0M raised

Biotech

Healthcare

Headquarters: Shanghai
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: minghuipharma.com
Total Funding: $131.0M
Last Round: $131.0M Venture RoundAug 2025
Rounds: 1

About

Minghui Pharmaceutical is a Shanghai-based, late-stage clinical biopharmaceutical company developing innovative medicines for oncology and immunology. Its pipeline includes a topical JAK inhibitor under NDA review in China, a subcutaneous IGF-1R antibody in Phase 3 trials for thyroid eye disease, and a PD-1/VEGF bispecific antibody in Phase 2 trials. The company raised $131M in Pre-IPO financing in 2025 led by OrbiMed and Qiming Venture Partners.

Summary

Minghui Pharmaceutical is a Biotech company based in Shanghai, China, founded in 2018. It has raised $131.0M in total across 1 round, most recently a $131.0M Venture Round round in Aug 2025. Investors include OrbiMed, Qiming VP and TF Capital.